Calcitonin Gene-Related Peptide and Trigeminal Neuralgia

Calcitonin gene-related peptide (CGRP) is known to be involved in the pathophysiology of migraine headache. CGRP may play a role in the mechanisms of somatic, visceral, neuropathic, and inflammatory pain. Currently, there are multiple new biologic therapies targeting CGRP which have been approved fo...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:SN comprehensive clinical medicine Ročník 5; číslo 1; s. 75
Hlavní autori: Retsky, Rachel, Ashina, Sait, Oved, Daniel, Sharon, Roni
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Cham Springer International Publishing 01.12.2023
Springer Nature B.V
Predmet:
Ablation
Headaches
Medicine
Medicine & Public Health
Migraine
Pain
Peptides
Review
Side effects
Topical Collection on Medicine
United States > US
Calcitonin gene-related peptide
Pain
Treatment
Trigeminal neuralgia
ISSN:2523-8973, 2523-8973
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Calcitonin gene-related peptide (CGRP) is known to be involved in the pathophysiology of migraine headache. CGRP may play a role in the mechanisms of somatic, visceral, neuropathic, and inflammatory pain. Currently, there are multiple new biologic therapies targeting CGRP which have been approved for the acute and preventive treatment of migraine. Studies have also shown CGRP to be involved in the pathophysiology of trigeminal neuralgia (TN), an often severe and refractory facial pain condition. This article outlines the pathophysiology of trigeminal neuralgia and the role CGRP may play in this condition. We discuss the current evidence on CGRP in trigeminal neuralgia and how modulation of CGRP may be a potential target in the treatment of trigeminal neuralgia in the future. With many similarities in the pathophysiology and efficacy of drug therapies for migraine and trigeminal neuralgia, we hypothesize that targeting CGRP may be a potential mechanism of pain relief in trigeminal neuralgia.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:2523-8973
2523-8973
DOI:10.1007/s42399-023-01407-1